2008 annual financial data
Halozyme Therapeutics 2008 Financial results
Direct answer
Revenue was 8,764,139 USD.
Operating income was -50,434,702 USD and net income was -48,654,199 USD.
Operating cash flow was -35,373,864 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,764,139 USD
- Operating income
- -50,434,702 USD
- Net income
- -48,654,199 USD
- Operating cash flow
- -35,373,864 USD
Explore related company data
View all 2008 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Halozyme Therapeutics financial years